Intermolecular interaction analysis methods based on fluorescence resonance energy transfer
By using covalent labeling of small molecule dye donor-acceptor pairs and FRET analysis, the limitations of the existing FRET method have been overcome. This enables quantitative and qualitative analysis of intermolecular interactions, expands the application scope, simplifies sample processing, and improves analytical efficiency.
Patent Information
- Application Number
- CN202311717149.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-14
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-12-14
AI Technical Summary
Existing FRET-based molecular interaction analysis methods are mainly limited to protein-protein interactions and are difficult to apply to other types of interaction analysis, such as protein-small molecule compounds. Furthermore, the use of fluorescent proteins and quantum dots has issues such as long expression cycles, large background interference, toxicity, and compatibility.
Covalent labeling was performed using small molecule dye donor-acceptor pairs. Intermolecular interactions were analyzed by fluorescence resonance energy transfer (FRET). EFRET and KD values were calculated using formulas (6) and (7), thus expanding the application scope of FRET.
This enables qualitative and quantitative analysis of intermolecular interactions, expands the application scope of FRET, simplifies sample processing, reduces sample consumption, and improves analytical efficiency.
Smart Images

Figure CN117686477B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of intermolecular interaction analysis technology, specifically relating to an intermolecular interaction analysis method based on fluorescence resonance energy transfer. Background Technology
[0002] Intermolecular interactions refer to the interactions or influences between different molecules. The strength of an intermolecular interaction refers to the magnitude of the attractive or repulsive forces between two or more molecules. These interactions can affect the structure, stability, and function of molecules and play a crucial role in fields such as chemistry, biology, and physics. Intermolecular interactions can be divided into two levels: bimolecular interactions and multimolecular interactions. Bimolecular interactions refer to the interactions between two molecules. These interactions are essential for molecular structure, chemical reactions, and interactions between biomolecules. For example, in enzyme-substrate interactions, hydrogen bonds and other interactions between the substrate and the enzyme's active site can affect the efficiency and selectivity of enzyme catalysis. Multimolecular interactions refer to interactions between more than two molecules. They involve the collective behavior and synergistic effects among multiple molecules. Multimolecular interactions play an important role in many systems, such as aggregates in solution, spatial arrangements in crystals, and catalyst / reactant coordination complexes in chemical reactions.
[0003] Affinity K D The binding constant (K) is a physical quantity describing the strength of intermolecular interactions. It represents the equilibrium ratio between free molecules and bound ligands in solution under given conditions. Intermolecular interactions determine the affinity K between the ligand and the acceptor. D Stronger interactions typically correspond to smaller K values. D A value indicates a strong binding. Molecular interaction analysis is a scientific method for studying the nature, strength, and mechanism of interactions between molecules. Through intermolecular interaction analysis, we can gain a deeper understanding of the interaction forces between molecules and reveal their importance and application value in fields such as chemistry, biology, and materials science. This analysis can include quantitative measurements and qualitative descriptions, aiming to provide a comprehensive understanding of interaction strength, kinetic behavior, and thermodynamic properties.
[0004] Fluorescence resonance energy transfer (FRET) methods have wide applications in life sciences, drug discovery, chemistry, and materials science. It not only provides quantitative information about intermolecular interactions but also reveals important information about molecular structure, conformation, and dynamic changes, offering a powerful tool for a deeper understanding of molecular function and related biological processes. FRET is a non-radiative energy transfer phenomenon suitable for systems that meet spectral overlap and proximity requirements. Energy is transferred from the excited state of the donor fluorophore (D) to the ground state of the acceptor fluorophore (A) through dipole-dipole coupling. FRET exhibits a reciprocal sixth-order distance dependence, thus enabling the detection of nanometer-scale distances, typically ranging from 1 to 10 nanometers (up to 20 nanometers for some atypical FRET pairs). Compared to other techniques (such as X-ray crystallography), FRET is simpler and easier to perform, can be measured in living cells, and can be operated using standard experimental equipment. FRET is widely used in research areas matching the length scale of biomacromolecules. It is renowned for its nanometer-scale distance measurements and is known as the "molecular ruler" for probing the structure of biomacromolecules. Beyond structural studies, FRET can also be used to monitor the dynamic processes of intracellular protein-protein interactions and other biological signal transduction processes. FRET assays and sensors play a powerful role in biological research because they allow for real-time, in-situ detection without any intervention steps (such as washing). Some target processes suitable for FRET assays include the binding and dissociation of biomolecules, conformational changes, and changes in the local environment, as these can lead to switching between high (on) and low (off) FRET states. Therefore, FRET is an important technical tool with wide applications in biological research. Its nanometer-scale measurements contribute to understanding the structure and interactions of biomolecules and enable dynamic monitoring of signal transduction in many bioassays.
[0005] Early FRET-based methods were used only for qualitative or relative quantitative analysis of molecular interactions. In recent years, FRET-based methods have enabled quantitative analysis of molecular interactions using fluorescent protein-fluorescent protein donor-acceptor pairs (Jiang L, Xiong Z, Song Y, et al. Protein–Protein Affinity Determination by Quantitative FRET Quenching[J]. Scientific reports, 2019). This method utilizes the principle of equilibrium kinetics, based on the fluorescence signal of the donor-acceptor pair, to achieve quantitative analysis of K+-fluorescent protein ... D The value is calculated using a fitting formula. ; in, ; K can be obtained by fitting the data. D The value and a constant n, which is a constant related to the FRET efficiency between CyPet-SUMO1 and YPet-Ubc9.
[0006] Fluorescent proteins (FLIPs) are a class of naturally occurring proteins in organisms that absorb light of specific wavelengths and emit fluorescence of specific colors. In FRET research, FLIPs can be used as donors or acceptors to label target molecules, thereby enabling the detection and quantification of molecular interactions (Jiang L, Xiong Z, Song Y, et al. Protein–Protein Affinity Determination by Quantitative FRET Quenching[J]. Scientific reports, 2019). However, the expression cycle of fusion proteins often takes 1-3 weeks, requiring processes such as linking the target gene to an expression vector, transforming it into host cells, culturing and inducing host cells to produce the fusion protein, and finally extracting and purifying the target protein. Furthermore, the emission spectrum of FLIPs overlaps significantly with that of the receiver, potentially causing background fluorescence interference and reducing the sensitivity and specificity of the FRET signal. In addition, the large size of FLIPs may affect the structure and function of the target molecule, leading to biased or misleading results. Therefore, further improvements to methods for quantitative analysis of molecular interactions using FRET are particularly important.
[0007] Quantum dots are a class of nanomaterials with narrow emission peaks, high fluorescence quantum yields, and long lifetimes. In FRET research, quantum dots can be used as donors or acceptors, providing strong and stable fluorescence signals for the detection and quantification of interactions between target molecules. However, quantum dots typically require chemical synthesis, and some quantum dot materials may exhibit toxicity and compatibility issues, limiting their application in biological systems. Furthermore, surface modification and coupling processes for quantum dots may introduce additional steps, increasing technical complexity and operational difficulty. Moreover, the size and shape of quantum dots significantly influence their optical properties, requiring precise control and optimization; the relatively large size of quantum dots can also have a substantial impact on proteins.
[0008] In summary, current FRET-based quantitative analysis methods for molecular interactions are limited to protein-protein interactions, and these methods require the fusion expression of fluorescent proteins and the protein under study. Furthermore, for protein-nucleic acid, protein-small molecule compound, and protein-polysaccharide interactions, the inability of nucleic acids, small molecule compounds, and polysaccharides to be fused with fluorescent proteins restricts the application of this method in these areas. Therefore, it is necessary to develop new methods for analyzing intermolecular interactions to broaden their application scope and make them suitable for analyzing a wider range of molecular interactions. Summary of the Invention
[0009] To overcome the shortcomings of the prior art, this invention provides a method for analyzing intermolecular interactions based on fluorescence resonance energy transfer. This method utilizes the fluorescence resonance energy transfer phenomenon occurring between small molecule dyes to study intermolecular interactions, enabling not only qualitative analysis but also quantitative analysis of intermolecular interactions, and obtaining K... D Value and E max value.
[0010] To achieve the above objectives, the technical solution adopted by the present invention is as follows: This invention provides a method for analyzing intermolecular interactions based on fluorescence resonance energy transfer, comprising the following steps: S1. Fluorescent dye donor-acceptor pairs are used to covalently label the test molecules with small molecule dyes to obtain donor-labeled molecule D-α and acceptor-labeled molecule A-β. S2. Use a buffer solution to dilute D-α and A-β to avoid D-α and A-β always being within the distance where resonant energy transfer occurs; S3. Incubate the diluted D-α and A-β, and set up a control with buffer solution. Then, use a microplate reader to detect the FRET signal and perform FRET analysis. S4. Data Processing and Analysis: First, calculate the fluorescence resonance energy transfer efficiency E according to formula (6). FRET : ; In the formula, ID is the fluorescence intensity of the control group, and IDA is the fluorescence intensity of the experimental group; E FRETCommon calculation methods include calculation based on the Donor-Acceptor ratio or calculation based on the FRET efficiency formula. Formula (6) is derived from: Medintz, IL & Hildebrandt, N. (eds) FRET – Förster Resonance EnergyTransfer from Theory to Applications (Wiley-VCH, 2013).
[0011] Then calculate the E FRET As Y, the corresponding concentration is input as X. The software has fitting capabilities (e.g., GraphPad Prism (https: / / www.graphpad-prism.cn / ), Origin (a scientific graphing and data analysis software developed by OriginLab, supporting operation under Microsoft Windows), IBM SPSS (https: / / www.ibm.com / cn-zh / spss)). The software is then fitted according to formula (7). After fitting using software with nonlinear fitting capabilities [e.g., GraphPad Prism (https: / / www.graphpad-prism.cn / ); Origin (developed by OriginLab); IBM SPSS (https: / / www.ibm.com / cn-zh / spss)], the values of EMax and KD are obtained: ; Where EMax represents the maximum value of EFRET at a given D-α concentration; A represents the final concentration of D-α; X is the final concentration of A-β; KD is the dissociation constant, K D The value represents the strength of the intermolecular interaction.
[0012] In step S2, the fluorescent dye labeling of molecules is achieved through a chemical reaction, where selected donor-acceptor pairs covalently label the molecules. The molecule labeled with the donor is defined as D-α, and the molecule labeled with the acceptor is defined as A-β. This mainly includes the following operations: ①Activation: Activating the functional groups of fluorescent dyes with the target molecules. This can be achieved by introducing reactive groups (such as amines, hydroxyl groups, disulfides, etc.) onto the fluorescent dye molecules. ② Linkage: The activated fluorescent dye reacts chemically with functional groups in the target molecule that have corresponding reaction sites, forming a covalent link. Common reactions include the reaction of amino groups with isocyanates, the reaction of hydroxyl groups with acid anhydrides, and the reaction of thiols with dienes, etc. ③ Purification: After ligation with the fluorescent dye, a purification step is usually required to remove unreacted fluorescent dye and other impurities. This can be accomplished through methods such as column chromatography, gel electrophoresis, and solution concentration. ④ Validation: Verification is needed to confirm whether the labeled molecule has been successfully ligated with the fluorescent dye. Commonly used methods include UV-Vis absorption spectroscopy, fluorescence spectroscopy, and mass spectrometry to ensure that the labeled molecule has the desired optical properties and structure.
[0013] It should be noted that formula (7) is an original invention, and the derivation process is as follows: Based on the molecular interaction reaction equation: ; dissociation constant K D for: ; Let the final concentration of D-α be a, and the final concentration of A-β be X. Let the value of EFRET be Y when the final concentrations of D-α and A-β are a and X, and the maximum value of EFRET be E. max When molecules interact, they form a certain spatial relative position. After fluorescence excitation, there is a linear relationship between the number of donor molecules undergoing energy transfer and EFRET, specifically the following relationship: ; Therefore: ; ; Therefore, K D for: ; Solving the equation yields the value of Y, which is formula (7). Here, [D-α]bound represents the concentration of bound D-α; [D-α]free represents the concentration of free D-α; and [A-β]free represents the concentration of free A-β.
[0014] Preferably, the donor-acceptor pair in step S1 includes Alexa Fluor 488-Alexa Fluor 555 (R0=7nm) and Alexa Fluor 594-Alexa Fluor 647 (R0=8.5 nm).
[0015] This invention uses two donor-acceptor pairs: Alexa Fluor 488-Alexa Fluor 555 (R0=7 nm) and Alexa Fluor 594-Alexa Fluor 647 (R0=8.5 nm), which have a relatively large Förster distance (R0). However, this invention is not limited to the above two in the selection of donor-acceptor pairs. In principle, as long as the molecules labeled by the donor and acceptor can undergo fluorescence resonance energy transfer, the donor-acceptor pairs can be matched according to the object to be studied and the existing conditions in the laboratory.
[0016] The following is the method for calculating R0 (Source: Medintz, IL & Hildebrandt, N. (eds) FRET – Förster Resonance Energy Transfer from Theory to Applications (Wiley-VCH, 2013).): ; in ; In the above formula, R0 represents the Fest distance, which is the distance at which the energy transfer efficiency between the donor and acceptor drops to 50%. 2 : Orientation factor, considering the relative orientation relationship between the donor and recipient. N -4 : Refractive index correction factor, taking into account the effect of the refractive index of the medium on FRET efficiency. Q D : Quantum yield of the donor, representing the percentage of photons absorbed by the donor that can be emitted as fluorescence. J(λ): Spectral overlap integral, used to describe the degree of overlap between the donor fluorescence spectrum and the acceptor absorption spectrum. F_D(λ): Emission spectral intensity of the donor. ε_A(λ): Molar absorptivity of the acceptor, representing the intensity of light absorbed per unit concentration of the acceptor. λ: Wavelength, representing the specific wavelength of light.
[0017] This invention enhances biological significance by selecting different Y values for formula derivation. Furthermore, it utilizes the fluorescence resonance energy transfer (FRET) phenomenon between small molecule dyes with larger R0 values (R0 > 7 nm) to achieve qualitative and quantitative characterization of intermolecular interaction strength, enabling the characterization of molecular interactions with larger spatial volumes. Simultaneously, this invention expands the application scope of FRET in molecular interactions, enabling the analysis not only of protein-protein interactions but also of other interaction types such as protein-small molecule compounds.
[0018] Preferably, in step S2, D-α and A-β are diluted according to the following formula so that the distance d between D-α and A-β is greater than 1.5 times R0: ; In the formula, C is the concentration of D-α or A-β.
[0019] D-α and A-β are diluted, and the final concentrations of both in the test system should be such that D-α and A-β are always within the distance (d) where resonance energy transfer (FRET) occurs. According to the principle of FRET, current instruments can sensitively detect the corresponding energy transfer signal when the spatial distance between the donor and acceptor pair is within 1.5 times R0 (FRET as a biomolecular research tool - understanding its potential while avoiding pitfalls, https: / / www.nature.com / articles / s41592-019-0530-8). Therefore, in the presence of excitation light, fluorescence resonance energy transfer will occur when the distance between D-α and A-β is less than 1.5 times R0. Thus, when the concentrations of D-α and A-β exceed a certain value, the two molecules remain very close due to the high concentration, and even if the two molecules themselves do not interact, a FRET signal will occur. This is a false interaction, resulting in a false positive result.
[0020] For example, assuming the resonant energy transfer distance (d) is 10 nm, it can be calculated using the following formula (formula source: Chandrasekhar, S. Stochastic problems in physics and astronomy. Rev. Mod.Phys. 15, 1–89 (1943).): ; When the concentration (C) of A-β exceeds 200 μM, the distance between D-α and A-β is always less than 10 nm. Therefore, in this case, the concentration of A-β needs to be controlled below 200 μM.
[0021] Preferably, the buffer solution in step S2 includes PBST and HEPES.
[0022] Preferably, the control in step S2 is to replace A-β with the buffer solution used.
[0023] Preferably, in step S3, when performing FRET analysis, it is necessary to obtain the background signal from the non-fluorescent sample and subtract the background signal from the actual data in order to correct the background noise and perform signal correction.
[0024] Furthermore, in FRET analysis, the horizontal axis in the scatter plot is logarithmic, based on Log10. This choice allows the horizontal axis values to cover a wider range and better illustrate the proportional relationships between data points. By using a logarithmic axis, changes in data at different orders of magnitude can be observed more clearly, thereby improving the accuracy of data analysis and interpretation.
[0025] Preferably, in step S3, the diluted D-α and A-β are incubated in equal volumes.
[0026] Place equal volumes of diluted D-α and A-β molecules into the same reaction vessel or test tube. Gently mix the labeled molecule sample, ensuring they are homogeneously mixed. Mixing can be done using a shaker, inverted tube, or other similar methods. After mixing, seal the reaction vessel or test tube to prevent evaporation and contamination. Incubate the mixed labeled molecule sample in a thermostat or incubator. Incubation conditions (such as temperature and humidity) are determined based on experimental requirements and the characteristics of the labeled molecules. Generally, an incubation time of 5 minutes is set, ensuring a constant temperature throughout the incubation process.
[0027] Place the experimental samples in a suitable experimental setup containing a PMT detector to ensure the detection of the FRET signal. Adjust the gain or sensitivity of the PMT detector to fit the expected fluorescence signal intensity range. This maximizes the detection sensitivity and avoids oversaturation or noise interference. Begin acquiring the FRET signal. Detect the FRET effect by exciting the donor molecule and observing the emission fluorescence signal of the acceptor molecule. During acquisition, ensure the PMT detector is stable and record the obtained signal intensity. Depending on experimental requirements, the donor or acceptor can be excited and detected separately to obtain reference values for their fluorescence intensity.
[0028] Preferably, intermolecular interactions can also be qualitatively analyzed using the following method: the qualitative analysis only requires analyzing the fluorescence intensity values (ID) of the control group and the fluorescence intensity values (IDA) of the experimental group. Specific qualitative analysis includes: Method 1: Calculate EFRET according to formula (6). When EFRET is greater than 0, it means that the molecules have interacted. Method 2: This means that molecules interact with each other; Method 3: This means that molecules interact with each other; Method 4: This means that molecules interact with each other; Method 5: This refers to the interaction between molecules.
[0029] Compared with the prior art, the beneficial effects of the present invention are: This invention provides a method for analyzing intermolecular interactions based on fluorescence resonance energy transfer (FRET). The method involves covalently labeling the analyte with a small-molecule dye, and then characterizing the strength of the intermolecular interactions using the FRET between these dyes. The advantages are as follows: (1) The donor-acceptor pair used in this invention has an R0 greater than 7 nm, which can characterize interaction pairs with larger volumes; (2) The fluorescent labeling of the protein can be completed within 1 hour, which is a significant advantage compared to the 1-3 week construction cycle of fusion proteins; (3) The present invention consumes a small amount of sample, requiring only μg of sample; (4) A new method for calculating K was proposed. D The fitting formula was derived by using different Y values to make the formula more biologically meaningful and practically applicable. (5) It expands the application scope of FRET in molecular interactions, enabling the analysis of not only protein-protein interactions, but also other types of interactions such as protein-small molecule compounds. Attached Figure Description
[0030] Figure 1 The affinity data between the SARS-CoV-2 N protein and antibody MAb15 were calculated using the existing method [Formula (1)]. Figure 2 The affinity data between the SARS-CoV-2 N protein and antibody MAb15 calculated using the calculation method of the present invention [Formula (7)]; Figure 3 The affinity data between the SARS-CoV-2 N protein and antibody N019 were calculated using the existing method [Formula (1)]. Figure 4 The affinity data between the SARS-CoV-2 N protein and antibody N019 calculated using the calculation method of the present invention [Formula (7)]; Figure 5 The affinity data between the SARS-CoV-2 N protein and antibody N036 were calculated using the existing method [Formula (1)]. Figure 6 The affinity data between the SARS-CoV-2 N protein and antibody N036 calculated using the calculation method of the present invention [Formula (7)]; Figure 7The affinity data between the SARS-CoV-2 N protein and antibody L10H00101 were calculated using the existing method [Formula (1)]. Figure 8 The affinity data between the SARS-CoV-2 N protein and antibody L10H00101 calculated using the calculation method of the present invention [Formula (7)]; Figure 9 The affinity data between Streptavidin and Alexa fluor 594-TTTTTTTTTTTTTTTT Biotin were calculated using the existing method [Formula (1)]. Figure 10 The affinity data between Streptavidin and Alexa fluor594-TTTTTTTTTTTTTTT Biotin calculated using the calculation method of the present invention [Formula (7)]; Figure 11 The data are the raw data of the interaction between the SARS-CoV-2 N protein and the antibody MAb15, as well as the data that have been preliminarily processed by formulas (22) and (6); Figure 12 The results show the affinity between antibodies (MAb15, N019, N036, L10H00101) and the N protein of the novel coronavirus, as measured by SPR; where A is antibody N019, B is antibody N036, C is antibody L10H00101, and D is antibody MAb15. Figure 13 The results show the affinity between antibodies (MAb15, N019, N036, L10H00101) and the SARS-CoV-2 N protein, measured by different methods. Detailed Implementation
[0031] The specific embodiments of the present invention will be further described below. It should be noted that these descriptions are for the purpose of aiding understanding the present invention, but do not constitute a limitation thereof. Furthermore, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0032] Unless otherwise specified, the experimental methods used in the following embodiments are conventional methods, and the experimental materials used in the following embodiments are all available through conventional commercial channels.
[0033] The equipment, materials, and reagent solutions involved in this invention are as follows: 1. Instruments and equipment: as shown in the table below:
[0034] 2. Proteins, small molecules (1) The N protein (nucleocapsid protein) of SARS-CoV-2 is an important structural protein, also known as the core protein. The N protein plays a key role in the viral particle and participates in the packaging, replication and transcription of the viral genome.
[0035] The N protein is a highly conserved protein present in SARS-CoV-2 and its closely related viruses. Its main function is to bind to and protect the viral RNA genome and promote viral particle formation. The N protein also interacts with other viral proteins to regulate the viral replication process.
[0036] Due to the importance of the N protein in viruses, the recognition and binding of antibodies to this protein has significant biological and clinical implications. Anti-SARS-CoV-2 N protein antibodies are specific antibodies against the N protein produced by immunizing animals (such as mice, rabbits, etc.) or humans.
[0037] (2) Streptavidin and biotin are a commonly used affinity pair that are widely used in the fields of biochemistry, molecular biology and biotechnology.
[0038] Streptavidin is a protein produced by Streptomyces bacteria with extremely high affinity and specificity for biotin. It has four binding sites, allowing it to bind up to four biotin molecules simultaneously. Streptavidin is structurally very stable and maintains its affinity under numerous conditions.
[0039] Biotin, also known as vitamin H or vitamin B7, is a small organic molecule compound. In living organisms, biotin plays important physiological functions, including participating in carbon metabolism reactions and acting as a coenzyme in enzyme catalysis. In experiments, biotin is commonly used as a labeling or linker, forming a strong non-covalent interaction with streptavidin.
[0040] The specific proteins or small molecules involved in the following examples are shown in the table below: 3. Consumables 4. Reagents and solutions Example 1: Intermolecular Interaction Analysis Method Based on Fluorescence Resonance Energy Transfer 1. Fluorescent dye labeling of the anti-COVID-19 N protein antibody (COV19-PS-MAb15) (refer to the instructions for the Alexa Fluor® 488 Microscale Protein Labeling Kit) 1.1 Protein Preparation The purified protein was prepared to a concentration of 1 mg / mL in a buffer that does not contain major amino groups (e.g., ammonium ions, Tris, glycine, ethanolamine, triethylamine, glutathione) or imidazole. Specifically, 120 μL of phosphate buffer (PBS) was added to a 1.5 mL centrifuge tube, followed by 15 μL of 9.03 mg / mL MAb15, thus diluting the 9.03 mg / mL MAb15 to 1 mg / mL. Then, the A concentration of 1 mg / mL MAb15 was measured. 280 Turn on the UV-Vis spectroscopy function of the micro-volume spectrophotometer, use PBS as a blank control, add 2 μL of 1 mg / mL MAb15 to the probe of the micro-volume spectrophotometer, and record its absorption light at 280 nm, denoted as A. 280 A was measured 280 =1.224.
[0041] 1.2 Labeling reaction (1) Use the following formula to calculate the appropriate volume of the reactive dye solution to be used, the appropriate volume is given in the instruction manual, for MAb15, MR=55.
[0042] ; Where μg protein is the mass of the protein to be labeled, protein MW is the relative molecular mass of the protein to be labeled, MR is the molar ratio of dye:protein, and 11.3 is the concentration of the reaction dye. Substituting 100 μg of 150000 Da Anti-SARS-CoV-2 N protein antibody and MR=55 into the above formula, it is calculated that 3.24 μL of reaction dye needs to be added.
[0043] (2) Prepare a 1 M sodium bicarbonate solution by adding 1 mL of deionized water to the sodium bicarbonate vial (component B). Use a shaker or pipette to extract the solution from top to bottom until the reagent is completely dissolved.
[0044] (3) Transfer 100 μL of 1 mg / mL MAb15 to the reaction tube (component C), and add 10 μL of 1 M sodium bicarbonate. Mix thoroughly by repeatedly transferring the solution up and down.
[0045] (4) Add 10 μL of deionized water to a bottle of Alexa Fluor® 488 TFP ester (component A) and completely dissolve the contents of the bottle by up-and-down transfer. The concentration of the reactive dye stock solution is 11.3 nmol / μL.
[0046] (5) According to the formula (15), add 3.24 μL of reactive dye solution to the reaction tube containing the pH-adjusted protein and mix thoroughly by repeatedly moving the liquid up and down.
[0047] (6) Incubate the reaction mixture at room temperature for 15 minutes.
[0048] 1.3 Purification of the label (1) To separate the labeled protein from the unreacted dye, remove the gel resin container (component E) and a rotary filter (component D) from the kit. Completely suspend the gel resin by gently shaking the container; do not use a vortex or magnetic stir bar to agitate the material. Fill the upper chamber of the rotary filter with the suspended gel resin up to the lip, approximately 800 μL of resin is required. Centrifuge the rotary filter in a microcentrifuge at 16,000 × g for 15 seconds (including start-up time). Using a fixed-angle rotor will cause the resin to compact on both the low and high sides, at which point the edge of the resin bed on the low side should be approximately 2–3 mm above the green collar, while the edge on the high side should not exceed the top lip of the rotary filter. If using a basket rotor, the resin bed should fill about half of the upper chamber, approximately 5 mm.
[0049] (2) After preparing the rotary filter, use a pipette to drop no more than 50 μL of the conjugated reaction mixture onto the center of the resin bed surface. If the volume of the conjugated reaction is 51–100 μL, divide it into two smaller portions and purify them on separate rotary filters. Place the rotary filter in a microcentrifuge with the high side of the resin bed facing outwards and centrifuge at 16,000 × g for a total of 1 minute.
[0050] (3) Each collection tube now contains approximately 60-100 μL of purified dye-labeled protein in buffer. The procedure described in steps 1.1-2.3 above can be completed in about 30 minutes.
[0051] 1.4 Determine the Degree of Labeling (DOL) To determine the DOL of protein conjugates labeled with Alexa Fluor® 488 dye, spectrophotometry was performed based on 280 nm (A). 280 ) and 494 nm (A 494 Protein concentration is obtained by measuring the absorbance at a certain point.
[0052] (1) Turn on the NANO-500 spectrophotometer, enable the UV-Vis spectroscopy function, prepare a blank control using 2 μL of PBS, and then add 2 μL of labeled Anti-COVID-19 N protein antibody (COV19-PS-MAb15). Record A.494 and A 280 A was measured 494 =0.23, A 280 =0.173.
[0053] (2) Calculate the protein concentration in the sample using the following formula: ; In this equation, 0.11 is a factor used to correct for the contribution of the fluorophore to A280, A 280 The absorbance (A) of the labeled protein 280 =0.173), A 280 The absorbance of the protein before labeling is 1 mg / mL. 280 =1.224), where the dilution factor is the dilution ratio; in this experiment, the dilution factor = 6. The calculated concentration of the labeled Anti-COVID-19 N protein antibody (COV19-PS-MAb15) was 0.72 mg / mL, and the labeled Anti-COVID-19 N protein antibody (COV19-PS-MAb15) was named 488-MAb15.
[0054] (3) Calculate the molar concentration of the protein using the following formula: ; Substituting the result into formula (16) and the molecular weight of the Anti-COVID-19 N protein antibody (COV19-PS-MAb15) of 150,000 Da, we calculated to obtain 4.83E-06 M; The entire protein labeling process described above can be completed within one hour.
[0055] 2. Fluorescent dye labeling of the SARS-CoV-2 N protein (refer to the instructions for the Alexa Fluor® 555 Microscale Protein Labeling Kit) 2.1 Protein Preparation The purified protein was prepared to a concentration of 1 mg / mL in a buffer that does not contain major amino groups (e.g., ammonium ions, Tris, glycine, ethanolamine, triethylamine, glutathione) or imidazole. Specifically, 74 μL of phosphate-buffered saline (PBS) was added to a 1.5 mL centrifuge tube, followed by the addition of 50 μL of 2.48 mg / mL SARS-CoV-2 N protein, thus diluting the 2.48 mg / mL SARS-CoV-2 N protein to 1 mg / mL. Then, the A protein of the SARS-CoV-2 N protein at a concentration of 1 mg / mL was measured. 280 Turn on the UV-Vis spectroscopy function of the micro-volume spectrophotometer. Using PBS as a blank control, add 2 μL of 1 mg / mL COV-2NP to the probe of the micro-volume spectrophotometer and record its absorption light at 280 nm, denoted as A. 280 A was measured 280 =1.019.
[0056] 2.2 Labeling Reaction (1) Use the following formula to calculate the appropriate volume of the reactive dye solution to be used, the appropriate volume is provided in the instruction manual, for the SARS-CoV-2 N protein, MR=23.
[0057] ; Where μg protein is the mass of the protein to be labeled, protein MW is the relative molecular mass of the protein to be labeled, MR is the molar ratio of dye:protein, and 8.11 is the concentration of the reaction dye. Substituting 100 μg of 55000 Da SARS-CoV-2 N protein and MR=23 into the above formula, it is calculated that 3.24 μL of reaction dye needs to be added.
[0058] (2) Prepare a 1 M sodium bicarbonate solution by adding 1 mL of deionized water to the sodium bicarbonate vial (component B), and extract it up and down with a shaker or pipette until the reagent is completely dissolved.
[0059] (3) Transfer 100 μL of 1 mg / mL SARS-CoV-2 N protein to a reaction tube (component C), add 10 μL of 1 M sodium bicarbonate, and mix thoroughly by multiple up-and-down transfers.
[0060] (4) Add 10 μL of deionized water to a bottle of Alexa Fluor® 555 carboxylic acid, succinimidyl ester (component A) and completely dissolve the contents of the bottle by up-and-down transfer. The concentration of the reactive dye stock solution is 8.11 nmol / μL.
[0061] (5) According to the formula (18), 3.24 μL of reactive dye solution is added to the reaction tube containing the pH-adjusted protein and thoroughly mixed by repeatedly moving the liquid up and down.
[0062] (6) Incubate the reaction mixture at room temperature for 15 minutes.
[0063] 2.3 Purification of the label To separate the labeled protein from the unreacted dye, remove the gel resin container (component E) and a rotary filter (component D) from the kit. Completely suspend the gel resin by gently shaking the container; do not use a vortex or magnetic stir bar to agitate the material. Fill the upper chamber of the rotary filter with the suspended gel resin up to the lip, approximately 800 μL of resin is required. Centrifuge the rotary filter in a microcentrifuge at 16,000 × g for 15 seconds (including start-up time). Using a fixed-angle rotor will cause the resin to compact on both the low and high sides; the edge of the resin bed on the low side should extend approximately 2–3 mm above the green collar, while the edge on the high side should not exceed the top lip of the rotary filter. If using a pendulum rotor, the resin bed should fill about half of the upper chamber, approximately 5 mm.
[0064] (1) After preparing the rotary filter, use a pipette to drop no more than 50 μL of the conjugated reaction mixture onto the center of the resin bed surface. If the volume of the conjugated reaction is 51-100 μL, divide it into two smaller portions and purify them on separate rotary filters. Place the rotary filter in a microcentrifuge with the high side of the resin bed facing outwards and centrifuge at 16,000 × g for a total of 1 minute.
[0065] (2) Each collection tube now contains approximately 60-100 μL of purified dye-labeled protein in buffer. The procedure described in the labeling step of the SARS-CoV-2 N protein above can be completed in about 30 minutes.
[0066] 2.4 Determine the Degree of Labeling (DOL) To determine the DOL of protein conjugates labeled with Alexa Fluor® 555 dye, spectrophotometry was used by absorbing the absorbance at 280 nm (A). 280 ) and 555 nm (A 555 Protein concentration is obtained by measuring the absorbance at a certain point.
[0067] 1) Turn on the NANO-500 spectrophotometer, activate the UV-Vis spectroscopy function, prepare a blank control using 2 μL of PBS, then add 2 μL of labeled SARS-CoV-2 N protein and record A. 555 and A 280 A was measured 555 =1.313, A 280 =0.214.
[0068] 2) Calculate the protein concentration in the sample using the following formula: ; In this equation, 0.08 represents the fluorophore pair A. 280 A factor that modifies the contribution.280 The absorbance (A) of the labeled protein 280 =0.214), A280 of protein 1 mg / mL is the absorbance of the unlabeled protein (A 280 =1.019), where the dilution factor is the dilution ratio; in this experiment, the dilution factor = 5. The calculated concentration of the labeled SARS-CoV-2 N protein was 0.61 mg / mL, and the labeled SARS-CoV-2 N protein was named 555-N.
[0069] The molar concentration of protein can be calculated using the following formula: ; Substituting the result into formula (19) and the molecular weight of 555-N (55000 Da), we calculate 1.1E-05 M; The entire protein labeling process described above can be completed within one hour.
[0070] 3. Molecular interaction assay (ELISA reader detection) (1) Preparation of 488-MAb15 and 555-N working solutions: 1) Preparation of 40 nM 488-MAb15 working solution: Add 991.72 μL of PBST to a 1.5 mL centrifuge tube, then add 8.28 μL of 0.72 mg / mL 488-MAb15 (the required mass is 5.96 μg), and pipette to mix well; 2) Preparation of 555-N working solution: Add 1290 μL of PBST to a 1.5 mL centrifuge tube, then add 30 μL of 0.61 mg / mL 555-N (the required mass is 18.3 μg), and pipette to mix well; 3) Prepare 12 concentration gradients using the standard 2:1 dilution method, with a dilution volume of 660 μL and PBST solution used for dilution. Label the high concentration to the low concentration as A-β1, A-β2, ..., A-β10, A-β11, and A-β12, respectively.
[0071] (2) FRET working system configuration: Configure the FRET working system in the 384-well plate according to the table below, where 1, 2, and 3 are the column numbers of the wells, and A to P are the row numbers of the wells: (3) ELISA reader detection: The following table shows the settings parameters for the ELISA reader: Microplate reader reading results: 4. Data Processing: First, the background signal of the buffer solution is subtracted from the original signal, and then I is calculated. D The mean of three replicates in the control group. The formula is from the reference (Jiang L, Xiong Z, Song Y, et al. Protein–ProteinAffinity Determination by Quantitative FRET Quenching[J]. Scientific reports,2019): ; The formula applicable to this project is obtained as follows: ; Where, ΔEm 475 It is the change in emitted light intensity at 475 nm; Em 475([YPetUbc9]=X) This refers to the emission intensity at 475 nm when the concentration of YPet-Ubc9 is X; Em 475([YPetUbc9]=0) This is the emission intensity at 475 nm when the concentration of YPet-Ubc9 is 0. ΔEm 519 It is the change in emitted light intensity at 519 nm; Em 519([555-N]=X) This refers to the emitted light intensity at 519 nm when the concentration of 555-N is X; Em 519([555-N]=0) It is the emitted light intensity at 519 nm when the concentration of 555-N is 0.
[0072] ΔEm is calculated according to formula (22). 519 The result. Finally, E is calculated according to formula (6). FRET The value of .
[0073] ; In the formula, I D I represents the fluorescence intensity of the control group. DA The fluorescence intensity of the experimental group is shown.
[0074] Then respectively ΔEm 519The value is entered into Prism (an analysis software), and the corresponding 555-antigen (i.e., 555-N, which is the abbreviation for the labeled SARS Cov-2 N protein) concentration is entered. The K value is fitted using formula (1) from the literature (Jiang L, Xiong Z, Song Y, et al. Protein–Protein Affinity Determination by Quantitative FRET Quenching[J]. Scientific reports, 2019) to obtain K. D Value. For example... Figure 1 As shown, the calculated affinity (KD value) between the SARS-CoV-2 N protein and antibody MAb15 is 0.84 nM.
[0075] ; In equation (1), n is a constant related to the FRET efficiency between CyPet-SUMO1 and YPet-Ubc9, A represents the final concentration of D-α; X is the final concentration of A-β; K D It is the dissociation constant, Y=ΔEM 519 .
[0076] Then put E FRET The value of E and the corresponding 555-N concentration were fitted using formula (7) to obtain E. max and K D Value. For example... Figure 2 As shown, the affinity (K) between the SARS-CoV-2 N protein and antibody MAb15 was calculated. D The value is 0.81 nM, E max It is 0.55.
[0077] ; In equation (7), EMax represents the value of E at a given D-α concentration. FRET The maximum value; A represents the final concentration of D-α; X is the final concentration of A-β; Y=E FRET ;K D It is the dissociation constant, K D The value represents the strength of the intermolecular interaction.
[0078] It can be seen that the fitting result using the existing method [Formula (1)] is K. D and n; while the fitting result K obtained by using the calculation method of the present invention [Formula (9)] D and E max Among them, K between the two DThe values are comparable, indicating that the calculation method of this invention has high accuracy. Furthermore, n in formula (1) is related to EFRET, but the specific relationship is not clearly defined. And E... max This represents the energy transfer efficiency of the entire FRET system when the binding of D-α and A-β in the molecular interaction system reaches saturation. In comparison, the calculation results of this invention are more biologically significant.
[0079] At the same time, the affinity (K) between the SARS-CoV-2 N protein and antibody N019 was calculated using the same method. D The value is 3.41 nM, and Emax is 0.42 [K of formula (1)]. D The value is 2.99 nM. See details. Figure 3 , 4 The affinity (K036) between the SARS-CoV-2 N protein and antibody N036 was calculated. D The value is 2.62 nM, and Emax is 0.24 [K of formula (1)]. D The value is 2.70 nM. See details. Figure 5 , 6 The affinity (K) between the SARS-CoV-2 N protein and antibody L10H00101 was calculated. D The value is 1.43 nM, and Emax is 0.23 [the KD value of formula (1) is 1.46 nM], see details. Figure 7 , 8 .
[0080] In addition, commercially available proteins (AF647 Streptavidin, Bioss) and small molecules (Alexa fluor 594-TTTTTTTTTTTTTTT Biotin, synthesized using biotech primers) were already labeled with fluorescence. Molecular interaction assays (fluorescence signal detection using a microplate reader) were performed directly following step 3. Different dilution ratios were used for the receptor fluorescent molecules, employing a 5-fold dilution: 250 μL A-β1; A-β2: a mixture of 200 μL PSBT and 50 μL A-β1; A-β3: a mixture of 200 μL PBST and 50 μL A-β2; A-β4: a mixture of 200 μL PBST and 50 μL A-β3; A-β5: a mixture of 200 μL PBST and 50 μL A-β4; A-β6: a mixture of 200 μL PBST and 50 μL A-β5; A-β7: a mixture of 200 μL PBST and 50 μL... A-β6; A-β8: Mix 200 μL PBST and 50 μL A-β7; A-β9: Mix 200 μL PBST and 50 μL A-β8; A-β10: Mix 200 μL PBST and 50 μL A-β9; A-β11: Mix 200 μL PBST and 50 μL A-β10; A-β12: Mix 200 μL PBST and 50 μL A-β11. The detection conditions also differ and are as follows: The results showed that ( Figure 9 , 10 The affinity (K) between Streptavidin and Alexafluor 594-TTTTTTTTTTTTTTT Biotin was measured using the calculation method of this invention [Formula (7)]. D The value is 1.27 nM, E max K is 0.97 [Formula (1)] D The value is 1.26 nM.
[0081] Among them, the original data and the data preliminarily processed by formulas (22) and (6) are as follows: Figure 11 As shown.
[0082] Comparative Example 1 (performed on a Biacore 8K+ molecular interaction analyzer, referring to the Biacore 8K Molecular Interaction Analysis System Operating Guide). Surface plasmon resonance (SPR) is a real-time detection technique widely used in molecular interaction studies. Based on the plasmon resonance phenomenon on metal surfaces (typically gold or silver), it plays a crucial role in biomedicine, biochemistry, and drug development. This comparative example uses SPR to analyze the affinity between four antibodies (MAb15, N019, N036, and L10H00101) and an antigen (SARS-CoV-2 N protein) as a control.
[0083] 1. Pre-enrichment of ligands (1) Sample preparation: Take 1 μL of ligand (SARS-CoV-2 N protein) and add it to 99 μL of sodium acetate buffer (10 mM sodium acetate, pH 5.5, 5.0, 4.5, 4.0) at different pH values. Mix thoroughly. The final concentration of the ligand is approximately 10 μg / mL. If there are bubbles, centrifuge to remove them.
[0084] (2) Dock the CM5 chip into the device according to the steps in “1.4 Chip Placement” of the instruction manual.
[0085] (3) Click New method in the upper right corner of the Biacore 8K Control Software main interface, click Surface preparation, select pH scouting, click the open button in the lower right corner to enter the editing interface, and the sample contact time is 180s (default).
[0086] (4) Click the "Variables and positioning" button above to edit the sample name and placement location. Uncheck the box before "5-8 channels" and modify the sample name in "Analyte1 solution". (5) Click the "Plate Layout" button in the upper right corner. The system will jump to a new window. Check if the solution volume in the Bottles displayed on the screen is sufficient. Then, according to the sample position information displayed on the screen, prepare a sample of sufficient volume and place it in the designated position on the Plate of the corresponding Tray (the sample volume should be slightly larger than the displayed volume). Place the SARS-CoV-2 N protein diluted in sodium acetate at pH 5.5, 5.0, 4.5, and 4.0 in Plate1A1, B1, C1, and D1, respectively. Place 52 μl of sodium hydroxide (50 mM sodium hydroxide) in Plate1A2, B2, C2, and D2. Fill the other areas displaying Buffer with PBST. Place the 96-well plate in the designated Plate position of the corresponding sample and lock it. Then return it to the sample chamber and close the chamber door.
[0087] (6) Click the file save icon in the upper right corner to save the method file in a custom folder, click Save, then click Send to queue, and then click Ready to start below.
[0088] (7) After the pre-enrichment (pH scouting) program finishes running, click "Runs" at the top of the Biacore 8K Control Software main interface, locate the result file, and double-click to open it. Then, select "Run properties," click "Open evaluation software," and the interface will redirect to Biacore Insight Evaluation Software.
[0089] (8) In Biacore Insight Evaluation Software, click Predefined to find the corresponding analysis method (Surface preparation – pH scouting), and double-click to perform the analysis. In the redirected interface, click Data grouping: Custom in the upper left corner, and check the box before All channels to integrate the electrostatic adsorption results of the ligands at four different pH values onto the same graph for comparison. Finally, a sodium acetate solution at pH 5.0 was selected as the optimal coupling condition.
[0090] 2. Ligand coupling (1) Coupling refers to the process of immobilizing ligands onto a chip. Coupling methods vary depending on the chip and ligand. This experiment will use the most typical and commonly used coupling method—amino coupling. Through previous pre-enrichment experiments, suitable ligand concentrations and pH conditions for coupling experiments have been determined. Ligand coupling can be completed using the immobilization program in Biacore 8K Control Software.
[0091] (2) Calculation of ligand coupling amount RL. In this experiment, the molecular weight of the ligand (SARS-CoV-2 N protein) was 55 kD, and the molecular weight of the analyte (Anti-SARS-CoV-2 N protein antibody) was 150 kD. Considering the subsequent kinetic assay, Rmax was set to 100 RU. Since the ligand is an antigen, each antigen molecule can theoretically bind to one antibody molecule, therefore the stoichiometric ratio Sm is equal to 1. The ligand coupling amount RL was calculated using the following formula: ligand coupling level RL ≈ 36 U, actual coupling amount = 1.5RL ≈ 55 RU.
[0092] ; (3) Click "New method" in the upper right corner of the Biacore 8K Control Software main interface, click "Surface preparation", select "Immobilization", and click the "open" button in the lower right corner to enter the editing interface. In the "Chip type" drop-down menu, select "CM5". The default coupling method of this program is amino coupling (Amine). This experiment only uses channels 1-4, so remove the checkmark in front of channels 5-8. In this experiment, the ligand will be fixed on flow cell 2 (Fc2) in channels 1-4, while only activation and blocking will be performed on flow cell 1 (Fc1), without ligand fixation. Therefore, select "Fc2, activate / deactivate in 1". Modify the ligand injection time to 420s and modify the ligand name.
[0093] (4) Click “Positioning and plate layout” at the top. The system will jump to a new window. Check if the solution volume in the Bottles displayed on the screen is sufficient. Then, according to the sample position information displayed on the screen, prepare a sample of sufficient volume and place it in the designated position on the Plate of the corresponding Tray (the sample volume should be slightly larger than the displayed volume). Place the 96-well plate in the designated Plate position of the corresponding sample and lock it. Then return it to the sample chamber and close the chamber door.
[0094] (5) Click the file save icon in the upper right corner to save the method file in a custom folder, and click Save. Then click Send to queue. The system will automatically jump to a new interface. Confirm that the items displayed on the screen are placed correctly, confirm that the Buffer, Water, and Reagent are sufficient, and confirm that the positions of the tray and plate are consistent with the display. The whole process takes about 26 minutes. Click Ready to start below. In the pop-up window, save the result file to the corresponding folder. The system will then automatically run the Immobilization program.
[0095] (6) After the immobilization program finishes running, click "Runs" at the top of the Biacore 8K Control Software main interface, locate the results file, and double-click or click the "Open" button in the lower right corner to open it. The Results section displays the final ligand protein conjugation amount (Table 1). In this experiment, the ligand conjugation amount on flow cell 2 in channels 1-3 all reached the expected level. Click "Sensorgram" to view the entire conjugation process.
[0096] Table 1 Final ligand protein coupling amount 3. Selection of chip regeneration conditions The selection of regeneration conditions is a crucial step in the entire experiment, directly affecting the reproducibility of the results. This part utilizes the regeneration scouting program in Biacore 8K Control Software to select the optimal regeneration conditions. The analyte in this experiment was the Anti-SARS-CoV-2 N protein antibody (ABN019), and the selected regeneration conditions were Glycine 3.0–1.5.
[0097] (1) Click "New method" in the upper right corner of the Biacore 8K Control Software main interface, click "Assay development", select "Regeneration scouting", and click the "open" button in the lower right corner to enter the editing interface. Change the "Solution" in "Analyte1" to the analyte name, change the "Contact time" to 60s, and select the default "Variable" for "Solution" in "Regeneration1".
[0098] (2) Click “Variables and positioning” at the top to enter the new interface, and click Analysis. Select Channel 1 to perform surface testing, remove the checkmark in front of Channel 2-8, and fill in the name of the regeneration solution in Regeneration 1 Solution. A total of 5 replicates / cycles (2 replicates can be deleted according to the actual situation; 5 replicates are performed in this experiment).
[0099] (3) Click “Plate layout” in the upper right corner. The system will jump to a new window. Check if the solution volume in the Bottles displayed on the screen is sufficient. Then, according to the sample position information displayed on the screen, prepare a sufficient volume of sample [the preparation method for Anti-COVID-19 N protein antibodies (MAb15, N019, N036, L10H00101) is shown in Table 2], and place it in the designated position on the Plate of the corresponding Tray (the sample volume should be slightly larger than the displayed volume). Place the 96-well plate in the designated Plate position of the corresponding sample, lock it, and then return it to the sample chamber and close the chamber door.
[0100] Table 2 Preparation of Antibodies (4) Click the file save icon in the upper right corner to save the method file in a custom folder, and then click Save. Then click Send to queue. The system will automatically jump to a new interface. Confirm that the items displayed on the screen are placed correctly, confirm that the Buffer, Water, and Reagent are sufficient, and confirm that the positions of the tray and plate are consistent with the display. The whole process takes about 70 minutes. Click Ready to start below. In the pop-up window, save the result file to the corresponding folder. The system will then automatically run the Regeneration scouting program.
[0101] (5) Results Analysis. Ideal Regeneration Conditions: Effective regeneration conditions can remove all remaining analyte molecules (the signal returns to the baseline after regeneration). Through repeated injections and regenerations, the binding levels remained basically stable, with changes in binding levels within 10% compared to the first injection, maintaining the original activity.
[0102] 4. Multi-cycle dynamics detection of affinity Since the ligand (SARS-CoV-2 N protein) was already coupled on the chip in Part 2, Part 3 determined the regeneration reagent conditions for the analyte. Here, the Multi-cycle Kinetics / Affinity program in Biacore 8K Control Software will be used to complete the detection of affinity and kinetic data.
[0103] (1) In the opened Biacore 8K Control Software, click Newmethod in the upper right corner of the main interface, click Antibody / general, select Kinetics / affinity, and then double-click Multi-cycleKinetics / Affinity on the right.
[0104] (2) In the Method definition interface, select "set to fixed 25°C" for the sample chamber temperature and "nM" for the concentration unit, leaving other settings unchanged. In the Analysis window below, enter the default 25°C for the analysis temperature, 120s for the Contact time, 3600s for the Dissociation time, and 30 μl / min for the Flow rate. Click Add command to add the Regeneration command, with Solution set to Glycine 1,6, Contact time set to 30s, and Flow rate set to 30 μl / min. Leave all settings in Startup unchanged according to the system default values.
[0105] (3) Click “Variables and positioning” at the top to enter the new interface, and click Analysis. Select Channels 2-4 (the Fc2 channels of these 3 channels are all coupled with the same ligand) to perform affinity / kinetic analysis, and uncheck the boxes in front of Channels 1 and 5-8. Click Startup, and in the pop-up window, click Add cycle until you have 5 Startup cycles.
[0106] (4) Click Analysis, and in the pop-up table, fill in the sample name and concentration gradient in Analyte1 Solution (the first cycle is all zero concentration), and the concentration of the second cycle increases sequentially from channel 1 to 6. Click the button in the upper right corner, and select the pooling box below it to be displayed as √. The same samples or reagents will be merged immediately.
[0107] (5) Click “Plate Layout” in the upper right corner. The system will open a new window. Check if the solution volume in the Bottles displayed on the screen is sufficient. Then, according to the sample position information displayed on the screen, prepare a sample of sufficient volume and place it in the designated position on the Plate of the corresponding Tray (the sample volume should be slightly larger than the displayed volume). Place the 96-well plate in the designated Plate position of the corresponding sample and lock it. Then return it to the sample chamber and close the chamber door.
[0108] (6) Click the file save icon in the upper right corner to save the method file in a custom folder, and then click Save. Then click Send to queue. The system will automatically jump to a new interface. Confirm that the items displayed on the screen are placed correctly, confirm that the Buffer, Water, and Reagent are sufficient, and confirm that the positions of the tray and plate are consistent with the display. The whole process takes about 44 minutes. Click Ready to start below. In the pop-up window, save the result file to the corresponding folder. The system will then automatically run the Multi-cycle kinetics program.
[0109] (7) The results of the operation are shown in the figure. Figure 12 As can be seen from the figure, the affinity between antibody N019 and the N protein of the novel coronavirus is 5.65 nM ( Figure 12 A), the affinity between antibody N036 and the SARS-CoV-2 N protein is 3.49 nM ( Figure 12 B), the affinity between antibody L10H00101 and the SARS-CoV-2 N protein is 1.31 nM ( Figure 12 C), the affinity between antibody MAb15 and the SARS-CoV-2 N protein is 0.18 nM ( Figure 12 D).
[0110] At the same time, through Figure 13 The comparative detection results show that the method of the present invention can distinguish the interaction strength between different molecules, which is consistent with the results of commercial instruments. This indicates that the present invention can achieve the analysis effect of molecular interactions of commercial instruments that are generally recognized in the industry.
[0111] In summary, compared with existing methods for analyzing intermolecular interactions, this invention has the following advantages: (1) the R0 of the donor-acceptor pair used is greater than 7 nm, which can characterize interaction pairs with larger spatial volumes; (2) the fluorescent labeling of proteins can be completed within 1 h; (3) the sample consumption is small, requiring only μg of sample; (4) the fitting formula used to calculate KD is original to this project, and the formula derivation uses different Y values, making the formula more biologically meaningful and practically applicable. At the same time, this invention expands the application scope of FRET in molecular interactions, enabling not only the analysis of protein-protein interactions but also the analysis of other interaction types such as protein-small molecule compounds.
[0112] The embodiments of the present invention have been described in detail above, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions, and variations can be made to these embodiments without departing from the principles and spirit of the present invention, and these variations still fall within the protection scope of the present invention.
Claims
1. A method for analyzing intermolecular interactions based on fluorescence resonance energy transfer, characterized in that, Includes the following steps: S1. Fluorescent dye donor-acceptor pairs are used to covalently label the test molecules with small molecule dyes to obtain donor-labeled molecule D-α and acceptor-labeled molecule A-β. S2. Use a buffer solution to dilute D-α and A-β to avoid D-α and A-β always being within the distance where resonant energy transfer occurs; S3. Incubate the diluted D-α and A-β, and set up a control with buffer solution. Then, use a microplate reader to detect the FRET signal and perform FRET analysis. S4. Data Processing and Analysis: First, the fluorescence resonance energy transfer efficiency E is calculated according to formula (6). FRET : ; In the formula, I D I represents the fluorescence intensity of the control group. DA The fluorescence intensity of the experimental group; Then calculate the E FRET As Y, the corresponding concentration is input as X into software with fitting function, and then the fit is performed according to formula (7). After fitting with software with nonlinear fitting function, E is obtained. Max and K D Value: ; Among them, E Max This represents E at a given D-α concentration. FRET The maximum value; A represents the final concentration of D-α; X is the final concentration of A-β; K D It is the dissociation constant.
2. The method for analyzing intermolecular interactions based on fluorescence resonance energy transfer according to claim 1, characterized in that, The donor-acceptor pair described in step S1 includes Alexa Fluor 488-Alexa Fluor 555 and Alexa Fluor 594-Alexa Fluor 647.
3. The method for analyzing intermolecular interactions based on fluorescence resonance energy transfer according to claim 1, characterized in that, In step S2, D-α and A-β are diluted according to the following formula so that the distance d between D-α and A-β is greater than 1.5 times R0: ; In the formula, C is the concentration of D-α or A-β.
4. The method for analyzing intermolecular interactions based on fluorescence resonance energy transfer according to claim 1, characterized in that, The buffer solution in step S2 includes PBST and HEPES.
5. The method for analyzing intermolecular interactions based on fluorescence resonance energy transfer according to claim 1, characterized in that, The control in step S2 is to replace A-β with the buffer solution used.
6. The method for analyzing intermolecular interactions based on fluorescence resonance energy transfer according to claim 1, characterized in that, In step S3, when performing FRET analysis, it is necessary to obtain the background signal from the non-fluorescent sample and subtract the background signal from the actual data to correct the background noise and perform signal correction.
7. The method for analyzing intermolecular interactions based on fluorescence resonance energy transfer according to claim 1, characterized in that, In step S3, the diluted D-α and A-β are incubated in equal volumes.
8. The method for analyzing intermolecular interactions based on fluorescence resonance energy transfer according to claim 1, characterized in that, Qualitative analysis of intermolecular interactions can also be performed using the following method: Qualitative analysis only requires analyzing the fluorescence intensity value of the control group (Ig). D ) and the fluorescence intensity value of the experimental group (I DA That's all. Specific qualitative analysis includes: Method 1: Calculate E according to formula (6) FRET , when E FRET A value greater than 0 indicates that molecules have interacted. Method 2: This means that molecules interact with each other; Method 3: This means that molecules interact with each other; Method 4: This means that molecules interact with each other; Method 5: This refers to the interaction between molecules.
Citation Information
Patent Citations
Homogeneous time-resolved fluorescence analysis method of alpha-fetalprotein
CN102353790A
Monomolecular fluorescence resonance energy transfer method based on photo-activation
CN106918584A
